Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

Abdullah Kutlar, MD, Jennifer Pollock, PhD, Steffen E. Meiler, MD, Ryan Harris, PhD CEP, FACSM, Xu Hongyan, PhD, Leigh Wells, MSN, Latanya Bowman, RN, Sharon Jones, BS, David M. Pollock, PhD

Blood (2019) 134 (Supplement_1): 617.

https://doi.org/10.1182/blood-2019-130036

Published: 2019

Journal Articles

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD, Ralph Boccia, MD

Blood (2019) 134 (Supplement_1): 3445.

https://doi.org/10.1182/blood-2019-125793

Published: 2019

Journal Articles

Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens

Angie Mae Rodday, PhD, Theresa E. Hahn, PhD, Anita J Kumar, MDMS, Peter K Lindenauer, MD MSc, Jonathan W. Friedberg, MD, Andrew Matthew Evens, DO,MMSc, Susan K Parsons, MD MRP

Blood (2019) 134 (Supplement_1): 1563.

https://doi.org/10.1182/blood-2019-124141

Published: 2019

Journal Articles

Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database

Christopher C. Dvorak, MD, Zhun Cao, PhD, Kwanza Price, MPH, JeanPierre Coaquira, Craig Lipkin, Scott Robinson, Partow Kebriaei, MD

Blood (2019) 134 (Supplement_1): 4706.

https://doi.org/10.1182/blood-2019-123499

Published: 2019

Journal Articles

Downregulation of Sprr1a Contributes to the Pathobiology of Sickle Cell Disease

Donovan A Argueta, BSc, Anupam Aich, PhD, Jianxun Lei, PhD, Sergei Nekhai, PhD, Tatiana Ammosova, PhD, Xionghao Lin, PhD, Anindya Bagchi, PhD, Kalpna Gupta, PhD

Blood (2019) 134 (Supplement_1): 75.

https://doi.org/10.1182/blood-2019-129004

Published: 2019

Journal Articles

Lipidomic Profiling of Plasma Samples in Patients with Newly Diagnosed Multiple Myeloma; A Biomarker Study for Predicting the Response and Toxicities of Melphalan, Prednisolone and Bortezomib (MPB) Regimen : An Ancillary Study of the JCOG1105 (JCOG1105A1)

Masaki Ri, Shinsuke Iida, MD PhD, Dai Maruyama, MD PhD, Kosuke Saito, Yoshiro Saito, Satoshi Osaga, Masahiro Tohkin, Naoki Miyata, Kensei Tobinai, MD PhD, Noriko Fukuhara, MD PhD, Kana Miyazaki, MD PhD, Yosuke Minami, MD PhD, Norifumi Tsukamoto, MD PhD, Hideki Tsujimura, MD PhD, Makoto Yoshimitsu, MD PhD, Kenichi Miyamoto, Kunihiro Tsukasaki, MD PhD, Hirokazu Nagai, MD PhD

Blood (2019) 134 (Supplement_1): 3156.

https://doi.org/10.1182/blood-2019-122218

Published: 2019

Journal Articles

Prostaglandin E 2 Glyceryl Ester Contributes to Hyperalgesia in a Humanized Model Pf Sickle Cell Disease through P2Y 6 Receptors

Donald Simone, PhD, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 1075.

https://doi.org/10.1182/blood-2018-99-118945

Published: 2018

Journal Articles

Unplanned 30-Day Readmission and Predictors of Readmission in Patients with Neutropenic Fever : Insights from National Readmission Database

Supreet Kaur, MD, Aparna Saha, Mohamed Tausif Siddiqui, MD, Priti Poojary, Parita Ratnani, Sudarsan Kollimuttathuillam, MD, Abhishek Kumar, MD, Michael Maroules, MD

Blood (2018) 132 (Supplement 1): 4772.

https://doi.org/10.1182/blood-2018-99-120087

Published: 2018

Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD

Blood (2018) 132 (Supplement 1): 5567.

https://doi.org/10.1182/blood-2018-99-112334

Published: 2018

Journal Articles

Importance of Complete Parenteral Iron Replacement on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD

Blood (2018) 132 (Supplement 1): 2275.

https://doi.org/10.1182/blood-2018-99-113377

Published: 2018

Journal Articles

Targeting Elastase with Alpha1 Anti-Trypsin Reduces Hyperalgesia in Mice with Sickle Cell Disease

Aithanh Nguyen, Sophia Pantano, Waogwende Leonce Song-Naba, BS, Ritu Jha, MSc, Julia Nguyen, BS, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 724.

https://doi.org/10.1182/blood-2018-99-111872

Published: 2018

Journal Articles

Communication of Placental Iron Trafficking Proteins with Maternal and Fetal Iron Regulators

Sreenithi Santhakumar, MTech, Rekha Athiyarath, PhD, Anne George Cherian, MD, Vinod Abraham, MD, Biju George, DM, Eunice Sindhuvi Edison, PhD

Blood (2018) 132 (Supplement 1): 3629.

https://doi.org/10.1182/blood-2018-99-116344

Published: 2018

Journal Articles

Decreased Iron Utilization Leads to Dysregulation of Iron Homeostasis in Aplastic Anemia

Aruna Barade, MTech, Sreenithi Santhakumar, MTech, Biju George, DM, Eunice Sindhuvi Edison, PhD

Blood (2018) 132 (Supplement 1): 3872.

https://doi.org/10.1182/blood-2018-99-118010

Published: 2018

Journal Articles

Hepcidin and Erythroferrone in the Anemia of Low-Risk Myelodysplastic Syndromes

Gillen Oarbeascoa, MD, Sara Redondo, MD, Maria Jose Morán-Jiménez, MD, Amalia Domingo, MD, Cristina Muñoz-Linares, MD, Maria Isabel Moreno-Carralero, MD, Jose Maria Bellon, Juan Francisco del Campo Rincon, MD, Jose Luis Díez-Martín, MD PhD, Patricia Font, MD

Blood (2018) 132 (Supplement 1): 3085.

https://doi.org/10.1182/blood-2018-99-116992

Published: 2018

Journal Articles

Cost-Effectiveness of CPX-351 Versus 7+3 Regimen in the Treatment of Treatment-Related Acute Myeloid Leukemia (tAML) or AML with Myelodysplasia-Related Changes (MRC)

Anuraag Kansal, Mark Du, Oscar Herrera-Restrepo, Robert Leipold, Robert J. Ryan, Arthur C. Louie, Karen Chung

Blood (2017) 130 (Supplement 1): 4674.

https://doi.org/10.1182/blood.V130.Suppl_1.4674.4674

Published: 2017

Journal Articles

The Risk-Benefit Balance of Treatments for Hodgkin Lymphoma Reported in the Randomised and Non-Randomised Trial Setting: A Systematic Review

Mehul Dalal, PhD, Stephen Mitchell, PhD, Conor McCloskey, PhD, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD

Blood (2017) 130 (Supplement 1): 5605.

https://doi.org/10.1182/blood.V130.Suppl_1.5605.5605

Published: 2017

Journal Articles

Investigation of Circulating Plasma Micro RNAs As Biomarkers for Iron Status in Blood Donors

Margret Gudrun Gunnarsdóttir, Thorbjorn Jonsson, MDPhD, Anna Margret Halldorsdottir, MD PhD

Blood (2017) 130 (Supplement 1): 3498.

https://doi.org/10.1182/blood.V130.Suppl_1.3498.3498

Published: 2017

Journal Articles

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Mehul R Dalal, PhD, Stephen Mitchell, PhD, Conor McCloskey, PhD, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD

Blood (2017) 130 (Supplement 1): 5598.

https://doi.org/10.1182/blood.V130.Suppl_1.5598.5598

Published: 2017

Journal Articles

Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload

Fahim Thawer, Abdullah Kutlar, MD, Latanya Bowman, RN, Leigh Wells, MSN, Xu Hongyan, PhD, Niren Patel, MBBS, Pritam Bora, BA

Blood (2017) 130 (Supplement 1): 3518.

https://doi.org/10.1182/blood.V130.Suppl_1.3518.3518

Published: 2017

Journal Articles

High Sensitivity Hepcidin-25 Bioactive Elisas: Manual and Fully Automated System for the Quantification of Hepcidin-25 in Human Serum and Plasma

B. Uelker, Ian Cushman, PhD, T. Dudek, Dr. Matthias Herkert, PhD, Dr. Cyril E. Geacintov, PhD

Blood (2016) 128 (22): 4820.

https://doi.org/10.1182/blood.V128.22.4820.4820

Published: 2016

NARROW

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens

Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database

Downregulation of Sprr1a Contributes to the Pathobiology of Sickle Cell Disease

Lipidomic Profiling of Plasma Samples in Patients with Newly Diagnosed Multiple Myeloma; A Biomarker Study for Predicting the Response and Toxicities of Melphalan, Prednisolone and Bortezomib (MPB) Regimen : An Ancillary Study of the JCOG1105 (JCOG1105A1)

Prostaglandin E 2 Glyceryl Ester Contributes to Hyperalgesia in a Humanized Model Pf Sickle Cell Disease through P2Y 6 Receptors

Unplanned 30-Day Readmission and Predictors of Readmission in Patients with Neutropenic Fever : Insights from National Readmission Database

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Importance of Complete Parenteral Iron Replacement on Hemoglobin Normalization: A Retrospective Analysis

Targeting Elastase with Alpha1 Anti-Trypsin Reduces Hyperalgesia in Mice with Sickle Cell Disease

Communication of Placental Iron Trafficking Proteins with Maternal and Fetal Iron Regulators

Decreased Iron Utilization Leads to Dysregulation of Iron Homeostasis in Aplastic Anemia

Hepcidin and Erythroferrone in the Anemia of Low-Risk Myelodysplastic Syndromes

Cost-Effectiveness of CPX-351 Versus 7+3 Regimen in the Treatment of Treatment-Related Acute Myeloid Leukemia (tAML) or AML with Myelodysplasia-Related Changes (MRC)

The Risk-Benefit Balance of Treatments for Hodgkin Lymphoma Reported in the Randomised and Non-Randomised Trial Setting: A Systematic Review

Investigation of Circulating Plasma Micro RNAs As Biomarkers for Iron Status in Blood Donors

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload

High Sensitivity Hepcidin-25 Bioactive Elisas: Manual and Fully Automated System for the Quantification of Hepcidin-25 in Human Serum and Plasma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only